NovaBay Pharmaceuticals, Inc. (NBY)

0.7601 +0.01 (+1.10%) USD  |  NYAM  |  Feb 06, 16:00
0.8145 +0.05 (+7.16%) After-Hours: 05:51
More

NovaBay Pharmaceuticals SG&A Expense (TTM) : 8.584M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Cassava Sciences, Inc. 68.06M
cbdMD, Inc. 14.13M
ACADIA Pharmaceuticals, Inc. 523.36M
Alnylam Pharmaceuticals, Inc. 1.181B
Savara, Inc. 37.38M